Soleno Therapeutics Inc (SLNO)
US$ 73.26-1.31%
Price Chart
Key Statistics
Market Cap
$ 3.7B
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
774.87K
52W High
$ 80.99
52W Low
$ 36.93
Dividend Yield
0.00%
Beta
-2.67
Technicals
50-Day MA
63.893
200-Day MA
53.2747
52 Week High
80.99
52 Week Low
36.93
About SLNO
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.
Employees
115
Headquarters
Redwood City, CA
CEO
Dr. Anish Bhatnagar M.D.
Latest News
Is Soleno Therapeutics (SLNO) the Best Performing Healthcare Stock to Buy Now? - Yahoo Finance
4 days ago • Google News
SLNO Quantitative Stock Analysis - Nasdaq
2025-04-05 • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg